Expedited Review - Case Western Reserve University: One of ...



Expedited ReviewIntroductionResearch may be reviewed by the IRB under expedited procedures if all research activities present no more than minimal risk to human subjects and involve only procedures listed in one or more of the specific categories under 45 CFR 46.110.DefinitionsExpedited Modification is a proposed change in research related activities that does not materially affect an assessment of the risks and benefits of the study and does not substantially change the specific aims or design of the study.Expedited Review is review of research involving human subjects by the IRB Chair, Vice-Chair, or by one or more experienced IRB member reviewers designated by the Chair from among members of the IRB in accordance with the requirements set forth in 45 CFR 46.110.Experienced IRB Member is an IRB member who has actively served for a minimum of three (3) months, is certified in Human Subjects’ Protections under the CWRU Continuing Research Education Credits program and demonstrates a high level of understanding of the human research protection regulations with an ability to appropriately apply the regulations to research involving human subjects and is sensitive to the range of IRB discussions and resolution of controversial issues related to IRB reviews.Full Board Review is review of research involving human subjects conducted by the full IRB Board at a convened meeting where quorum is present and is in accordance with the requirements set forth in 45 CFR 46.108.Minimal Risk is when the probability and magnitude of harm or discomfort anticipated in the research is not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. Protocols deemed greater than minimal risk will be reviewed via Full Board Review. (45 CFR 46.102(i))PolicyThe federal regulation in 45 CFR 46.110 allows for certain kinds of research involving no more than minimal risk, and for minor changes in approved research to be reviewed using the expedited review procedure. Expedited review of research subject to the revised Common Rule will be conducted using the procedures described in this policy with the following variations: 1. Research that falls within the list of categories is presumed to be minimal risk unless the IRB determines and documents that the research involves more than minimal risk. [§46.110(b)(1)(i)] If the reviewer determines that the research involves more than minimal risk, it will be referred for review by the convened IRB 3. Continuing review of research is not required for research that qualifies for expedited review unless the IRB determines that is required and documents the rationale within the IRB recordThe Department of Health and Human Services (DHHS) has established a list of categories of research that may be reviewed by the IRB through expedited review (45 CFR 46.110(a) categories as listed below. Under 45 CFR 46.110(b), the CWRU IRB may use the expedited review procedure to review either or both of the following: Some or all of the research appearing on the list and found by the reviewer(s) to involve no more than minimal risk, The initial and continuing review of protocols and change requests are initially reviewed by the IRB Office to determine if the proposed research meets the regulatory criteria for expedited review. If the research meets the criteria stipulated under 45 CFR 46.110(b), it is forwarded for expedited review. Expedited Review Procedure and IRB ResponsibilitiesThe IRB Office reviews all submissions and if a submission is determined eligible for an expedited review, the IRB Chair, the Vice-Chair, and/or one or more IRB members conducts the expedited review via SpartaIRB. If an IRB member has specific expertise in the area of the research, the IRB Office will ask that member to conduct the review. The IRB Office and HRPP staff will select the appropriate IRB reviewer from a list of designated experienced board members. The IRB reviewer will have full access to the study and its relevant documents via SpartaIRB. The criteria for determining whether an IRB member is experienced to perform an expedited review is based on length of service (has actively served for at least three (3) months), showing a high level of understanding of the human research protection regulations and an ability to appropriately apply them to human subjects’ research; and routinely contributing to the discussions and resolution of controversial issues related to IRB reviews. They must also be certified in Human Subjects’ Protections under the CWRU CREC (Continuing Research Education Credits) program. Expedited Review of new protocols, at continuing review, and modifications to approved protocols The IRB Office is responsible for first confirming whether the new, continuing review, or modification, meets the criteria for expedited review. The IRB Office will then conduct a preliminary review of the protocol, which includes listing potential issues in SpartaIRB for the expedited reviewer(s) to consider. If the criteria are met, the study is forwarded to the designated reviewer who will complete an in-depth review of the research, and recommend the following actions may be taken:Approved as submittedRequest for modifications/additional information to secure approvalRefer for discussion at a convened full IRB meetingIn reviewing the research, the reviewers may exercise all of the authorities of the IRB except that the reviewers may not disapprove the research. A research activity may be disapproved only after review by a fully convened IRB as described in 45 CFR 46.108(b).If the proposed new, continuing or amendment submission is not eligible for review through the expedited review procedure, the IRB Office and/or the expedited reviewer(s) will request that the protocol be added as an agenda item for a convened IRB meeting.Continuing Review Previously Approved at Convened IRB MeetingThe federal regulations have provisions to allow the IRB to approve research previously approved at Full Board, using the expedited review procedure. In order for the expedited reviewer to approve the continuing review of a research study by expedited review, the IRB must ensure that the research has met the applicability criteria stipulated under 45 CFR 46.110(a) at a convened IRB meeting. (Per categories 9 as described in 45 CFR 46.110(b)).Modifications Initially Reviewed at Convened IRB meetingThe expedited review procedure may also be used to review minor changes in previously approved research during the period for which approval is authorized. Examples of modifications/additions that are deemed to be minor can be found in the Modification SOP. In order to approve modifications using the expedited review process, the reviewer must determine that the proposed changes/additions to the approved protocol are minimal risk. Research Involving PrisonersDepending on the nature of the study, research involving prisoners are reviewed by a fully convened IRB or follow the expedited review process with an experienced IRB reviewer who is also a prisoner representative. The IRB Office is responsible for reviewing and determining whether a research study involving prisoners is eligible for review through the expedited review process.Investigator ResponsibilitiesInvestigators must complete and submit a new protocol or modification form via . For new submissions, , the submission must include uploaded consent forms, data collection forms, recruitment materials, and all other document that are to be used in the research. For modifications, the submission must include any revised documents.IRB Reviewer ResponsibilitiesFor research reviews using the expedited review procedure, the IRB reviewer will conduct an in-depth review of the application and all study materials. The iRIS program includes a reviewer checklist to aid and guide reviewers.Initial Review of New Protocols: Information Received and Reviewed by ReviewerThe reviewer will receive and conduct an in-depth review of the new protocol application, proposed informed consent/assent/parental permission documents, recruitment materials, , and any other documents that are to be used in the research.The review process ensures that at least one person with appropriate scientific or scholarly expertise conducts an in-depth review of the protocol through the assignment of a qualified primary reviewer who is responsible for such review for each protocol.Amendments/Modifications to Previously Approved Research: Information Received and Reviewed by ReviewerThe expedited reviewer will receive and conduct an in-depth review of the modification form, all modified documents with the changes highlighted, all relevant currently IRB approved documents (approved consent, research plan), the investigator’s written explanation for the changes, and a clean copy of the revised documents. When an expedited reviewer finds areas within a submission that need modifications or clarifications, these are forwarded to the IRB Office who will then forward them to the investigator via SpartaIRB. Documentation of the actions and determinations of the reviewer including protocol-specific findings supporting those determinations will be part of the protocol’s SparatIRB file and will include:The category and circumstances that justify using expedited procedures;Any decision or actions by the reviewer;Any findings required under the regulations (including protocol-specific findings supporting this determination); andFrequency for the next continuing review for each initial or continuing review submission.Protocols that have received expedited review as new studies, continuing reviews, or modifications are listed in the monthly Notice of Committee report of the IRB Office’s administrative activities, which is presented to the IRB.DHHS, has published as a Notice in the Federal Register, a list of categories of research that may be reviewed by the IRB through an expedited review procedure. Only research that presents no more than minimal risk and falls under one of these categories can receive expedited approval. HHS will evaluate the list every eight (8) years …The activities listed should not be deemed to be of minimal risk simply because they are included on this list. Inclusion on this list only means that the activity is eligible for review through the expedited review procedure when the specific circumstances of the proposed research involve no more than minimal risk to human subjects. Other qualifications that apply:The categories in this list apply regardless of the age of subjects, except as noted.The expedited review procedure may not be used where identification of the subjects and/or their responses would reasonably place them at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, insurability, reputation, or be stigmatizing, unless reasonable and appropriate protections will be implemented so that risks related to invasion of privacy and breach of confidentiality are no greater than minimal.The expedited review procedure may not be used for classified research involving human subjects.IRBs are reminded that the standard requirements for informed consent (or its waiver, alteration, or exception) apply regardless of the type of review--expedited or convened--utilized by the IRB.Categories 1 through 7 pertain to both initial and continuing IRB review.Some research under categories 5 and 7 may qualify for exempt status, in which case the expedited rules do not apply.Category 1 – Drugs and Devices (This category does not apply to the CWRU IRB.)Clinical studies of drugs and/or devices only when one of the following is true:Research on drugs for which an investigational new drug (IND) application is not required Research on medical devices for which one of the following is true:An investigational device exemption (IDE)application is not required, or The medical device is cleared/approved for marketing and the medical device is being used in accordance with its cleared/approved labeling Category 2 - Blood SamplesCollection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows:From healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not exceed 550 ml in an 8 week period and collection may not occur more frequently than two times per week.From other adults and children, considering the age, weight, and health of the subjects, the collection procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection may not occur more frequently than two times per week.Category 3 - Biological SpecimensProspective collection of biological specimens for research purposes by noninvasive means.Examples: Hair and nail clippings in a non-disfiguring manner.Deciduous teeth at time of exfoliation or if routine patient care indicates a need for extraction.Permanent teeth if routine patient care indicates a need for extraction; Excreta and external secretions (including sweat).Uncannulated saliva collected either in an unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to the tongue.Placenta removed at delivery.Amniotic fluid obtained at the time of rupture of the membrane prior to or during labor.Supra- and subgingival dental plaque and calculus, provided the collection procedure is not more invasive than routine prophylactic scaling of the teeth and the process is accomplished in accordance with accepted prophylactic techniques.Mucosal and skin cells collected by buccal scraping or swab, skin swab, or mouth washings.Sputum collected after saline mist nebulization.Category 4 - Non-invasive Data CollectionCollection of data through noninvasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwaves. Where medical devices are employed, they must be cleared/approved for marketing. Examples of such procedures include: Physical sensors applied to the surface of the body or at a distance and do not involve input of significant amounts of energy into the subject or an invasion of the subject's privacy Weighing or testing sensory acuity Magnetic resonance imaging (MRI) Electrocardiography (ECG or EEG) Thermography Detection of naturally occurring radioactivity Electroretinography Ultrasound Diagnostic infrared imaging Doppler blood flow Echocardiography Moderate exercise, muscular strength testing, body composition assessment and flexibility testing where appropriate, given age, weight and health of the individual Category 5 - Data Collected for Non-research PurposesCollection of materials (data, documents, records or specimens) that have been, or will be collected solely for non-research purposes such as medical treatment or diagnosis.Category 6 - Data from RecordingsCollection of data from voice, video, digital or image recordings made for research purposes.Category 7 - Behavioral ResearchResearch on individual or group characteristics or behavior (including, but not limited to, research on perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies.Category 8 - Continuing ReviewsContinuing review of research previously approved by the convened IRB as follows:Category 8a (follow-up activities only)The research is permanently closed to the enrollment of new subjects; All subjects have completed all research-related interventions; andThe research remains active only for long-term follow-up of subjects.Category 8b (research not started)No subjects have been enrolled and no additional risks have been identified.Category 8c (data analysis only)The remaining research activities are limited to data analysis.Category 9 - Continuing Reviews approved by the Full BoardThe research is not conducted under an investigational new drug application or investigational device exemption; and The IRB has determined and documented at a convened meeting that the research involves no greater than minimal risk and no additional risks have been identified.References or Regulatory CitationsOHRP Guidance on the Use of Expedited Review Procedures45?CFR?46.110 HYPERLINK "" OHRP guidance Expedited Review Procedure - Permitted Categories of Research ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download